News for Magenta Therapeutics Inc (3MT.BE)

Published at

Mar 4, 2021 8:21 AM

by rttnews.com

mixed

mixed

KMPH Scores FDA Nod For ADHD Drug, MNOV Quits COVID-19 Vaccine Race, UTHR Gives Up On Trevyent

Today's Daily Dose brings you news about KemPharm scoring regulatory nod for its ADHD drug, expanded FDA approval for Pfizer's Lorbrena, United Therapeutics scrapping the development of Trevyent, Vir Biotechnology closing the enrollment in VIR-7831 arm of ACTIV-3 trial, and Takeda securing global rights to Ovid's investigational medicine Soticlestat.

VIR UTHR UTH.SG UTH.MU UTH.F UTH.BE RMN.F RMN.BE OVID OCGN MNOV KMPH GSK.L GSK GS7A.F GS7.SG GS7.MU GS7.F GS7.DE GS7.BE GLAXF 4875.T 2H51.F 2H51.BE 1OT.MU 1OT.F 1OT.BE UNC.MU UCBN.MX UCBJF SANA PFED.BA PFE.SG PFE.MX PFE.MU PFE.F PFE.DE PFE.BE PFE MGTA LHDX GHSI 3MT.MU 3MT.F 3MT.BE

Read more →
Published at

Feb 9, 2021 2:09 PM

by benzinga.com

mixed

mixed

The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 9) Abbott ...

VCYT VCEL RV7.MU RV7.F RV7.BE PPD NO1A.F NO1A.BE NAVB LGND LGDN.F LGDN.BE KRTX KALV JNCE ITOS ITCI IRWD INFI HALO GTHX GSK.L GS7A.F GS7.SG GS7.MU GS7.F GS7.DE GS7.BE GOVX GNPX GLAXF G1H.F G1H.BE FREQ FLGT.MX FLGT FGEN EVGN.TA EVGN EVAX ET82.SG ET82.MU ET82.F ET82.DU ET82.BE ENLV.TA ENLV EDAP EDA.F EDA.BE E8L.F DRNA DRIO DPL.F DMTK CXF.MU CXF.F CXF.BE CPTA.F CPTA.BE COLL CMRX CLGN CLDX CCXI AZRX AVIR AUTL ATQP.SG ATQP.MU ATQP.F ATQP.BE AEZS.TO AEZS ABT.SW ABT.MX ABT ABL.F ABL.DE ABBV 7F0.F 7F0.BE 6A3A.BE 4XC1.SG 4XC1.F 4XC1.BE 366.F 366.BE 354.F 2DE.F 2DE.BE 2CX.SG 2CX.MU 2CX.BE 23I.MU 23I.F 23I.BE 21J.SG 21J.MU 21J.F 21J.BE 1FG.F 1BT.F 1BT.BE 12V.F 12V.BE YP2A.F YP2A.BE VNDA VM4.SG VM4.F VIVO VERU US3528H109.F UG2.SG UG2.F UG2.BE TTOO TRIB TRBA.MU TPTX TERN TCE2.MU TCE2.F TCE2.BE TBIO SYBX SU6.F SU6.BE STRO SRDX SMMT SLRX SLN SIBN SESN SEEL S09.MU S09.F RNLX RENX.L RDUS RCUS RCKT QIA.SG QIA.MU QIA.F QIA.DE QIA.BE QGEN PRTK PRTA PROF PRN.TO PPBT.TA PPBT PLSE PCBK.MU PCBK.F PCBK.BE OTLK OT1A.MU OT1A.F OT1A.BE ORTX OPNT OCGN O7PA.MU O7PA.F NXEN.SG NXEN.F NXEN.BE NVV1.MU NVV1.F NVV1.BE NVAX.MX NVAX NOVN NK NBSE NARI N4CN.SG N4CN.F N4CN.BE MX9.F MSON MRNA MORF MJC.MU MJC.F MINA.MU MINA.F MINA.BE MGTA MEIP MDXG LIFE LHDX INSP INCY IMU.MU IMU.F IMU.DE IMU.BE IMGN IDYA ICY.MU ICY.F ICY.BE I76.F I3F.MU I3F.F I3F.BE HZNP HPR.MU HPR.F HBIO HBI.MU HBI.F GSK GMDA FP11.F FMW.MU FMW.F FMW.BE ETON DCPH D05.MU D05.F CSTL CCCC BOLT BLRX BEAM BCAB BBIO ATRS ATRC ANIX ANGO AMTI ALKS A5I.F 9IP1.MU 9IP1.F 6LU.F 6LU.BE 6L8.F 6L8.BE 471A.F 471A.BE 41ON.SG 41ON.MU 41ON.F 41ON.BE 3T2.MU 3T2.F 3T2.BE 3MT.MU 3MT.F 3MT.BE 31Y.MU 31Y.F 30J.MU 30J.F 30J.BE 2O9.F 2K3.MU 2K3.BE 2H51.F 2H51.BE 2DR.MU 2DR.F 2DR.BE 2CL.MU 2CL.F 1R8.SG 1R8.F 1R8.BE 0PT.F ZIOP XNCR XERS XE9.SG XE9.MU XE9.F XE9.BE WEK.SG WEK.MU WEK.F WEK.BE DYF1.MU DYF1.F DYF1.BE DVAX ANGN 2B3.MU 2B3.F 2B3.BE

Read more →
Published at

Feb 8, 2021 2:08 PM

by marketscreener.com

neutral

neutral

Magenta Therapeutics : to Present Additional Data from Phase 1 MGTA-145 Stem Cell Mobilization Program and Preclinical Updates on Targeting Conditioning Program at Transplantation and Cellular Therapy

– Magenta will present a total of five abstracts, including four oral presentations, highlighting clinical and preclinical data across its portfolio – ... | February 8, 2021

MGTA 3MT.MU 3MT.F 3MT.BE

Read more →